239 related articles for article (PubMed ID: 20825443)
1. Impact of parvovirus B19 infection on paediatric patients with haematological and/or oncological disorders.
Jitschin R; Peters O; Plentz A; Turowski P; Segerer H; Modrow S
Clin Microbiol Infect; 2011 Sep; 17(9):1336-42. PubMed ID: 20825443
[TBL] [Abstract][Full Text] [Related]
2. Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia.
Plentz A; Würdinger M; Kudlich M; Modrow S
J Clin Virol; 2013 Oct; 58(2):443-8. PubMed ID: 23916377
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.
Escher F; Modrow S; Sabi T; Kühl U; Lassner D; Schultheiss HP; Noutsias M
Med Sci Monit; 2008 Dec; 14(12):CR589-97. PubMed ID: 19043365
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
[TBL] [Abstract][Full Text] [Related]
7. Infection and immunity for human parvovirus B19 in patients with febrile exanthema.
Pedranti MS; Barbero P; Wolff C; Ghietto LM; Zapata M; Adamo MP
Epidemiol Infect; 2012 Mar; 140(3):454-61. PubMed ID: 21676356
[TBL] [Abstract][Full Text] [Related]
8. Human parvovirus B19 (B19V) infection in systemic sclerosis patients.
Zakrzewska K; Corcioli F; Carlsen KM; Giuggioli D; Fanci R; Rinieri A; Ferri C; Azzi A
Intervirology; 2009; 52(5):279-82. PubMed ID: 19672101
[TBL] [Abstract][Full Text] [Related]
9. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
Lehmann HW; Knöll A; Küster RM; Modrow S
Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
[TBL] [Abstract][Full Text] [Related]
10. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
11. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy.
Lindblom A; Heyman M; Gustafsson I; Norbeck O; Kaldensjö T; Vernby A; Henter JI; Tolfvenstam T; Broliden K
Clin Infect Dis; 2008 Feb; 46(4):528-36. PubMed ID: 18194100
[TBL] [Abstract][Full Text] [Related]
12. Genotype 3b of human parvovirus B19 detected from hospitalized children with solid malignancies in a North Indian tertiary care hospital.
Jain A; Jain P; Prakash S; Kumar A; Khan DN; Seth A; Gupta S; Kant R
J Med Virol; 2016 Nov; 88(11):1922-9. PubMed ID: 27116539
[TBL] [Abstract][Full Text] [Related]
13. Adaptive immune responses against parvovirus B19 in patients with myocardial disease.
Lindner J; Noutsias M; Lassner D; Wenzel J; Schultheiss HP; Kuehl U; Modrow S
J Clin Virol; 2009 Jan; 44(1):27-32. PubMed ID: 18980860
[TBL] [Abstract][Full Text] [Related]
14. Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.
Juhl D; Görg S; Hennig H
Vox Sang; 2014 Oct; 107(3):226-32. PubMed ID: 24916600
[TBL] [Abstract][Full Text] [Related]
15. The role of parvovirus B19 infection in childhood acute lymphoblastic leukemia.
Heegaard ED; Jensen L; Hornsleth A; Schmiegelow K
Pediatr Hematol Oncol; 1999; 16(4):329-34. PubMed ID: 10407869
[TBL] [Abstract][Full Text] [Related]
16. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
Cassinotti P; Burtonboy G; Fopp M; Siegl G
J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
[TBL] [Abstract][Full Text] [Related]
17. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.
Wang C; Heim A; Schlaphoff V; Suneetha PV; Stegmann KA; Jiang H; Krueger M; Fytili P; Schulz T; Cornberg M; Kandolf R; Manns MP; Bock CT; Wedemeyer H
J Med Virol; 2009 Dec; 81(12):2079-88. PubMed ID: 19856479
[TBL] [Abstract][Full Text] [Related]
19. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors.
Slavov SN; Haddad SK; Silva-Pinto AC; Amarilla AA; Alfonso HL; Aquino VH; Covas DT
J Med Virol; 2012 Oct; 84(10):1652-65. PubMed ID: 22930515
[TBL] [Abstract][Full Text] [Related]
20. Symptomatic parvovirus B19 infection caused by blood component transfusion.
Satake M; Hoshi Y; Taira R; Momose SY; Hino S; Tadokoro K
Transfusion; 2011 Sep; 51(9):1887-95. PubMed ID: 21332725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]